What is the recommended treatment for trichomoniasis (infection caused by Trichomonas vaginalis) in males?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis in Males

The recommended first-line treatment for trichomoniasis in males is metronidazole 2g orally in a single dose, which has cure rates of approximately 90-95%. 1

Treatment Regimens

  • Metronidazole 2g orally in a single dose is the preferred first-line treatment for males with trichomoniasis 1, 2
  • An alternative regimen is metronidazole 500mg orally twice daily for 7 days, which may be considered when medication adherence is not a concern 1, 3
  • Tinidazole 2g orally in a single dose is also effective for trichomoniasis treatment and is FDA-approved for this indication 4

Management of Sexual Partners

  • All sexual partners should be treated simultaneously to prevent reinfection, as trichomoniasis is a sexually transmitted disease 1, 5
  • Patients and their partners should abstain from sexual activity until both complete treatment and are asymptomatic 1, 6
  • Even asymptomatic partners should receive treatment to prevent reinfection, as the majority of men infected with T. vaginalis are asymptomatic 6, 7

Follow-Up Recommendations

  • Routine follow-up is unnecessary for men who become asymptomatic after treatment 1, 6
  • If symptoms persist after treatment, consider reinfection or resistant infection 1, 3

Treatment Failure Management

  • For first treatment failure, re-treat with metronidazole 500mg twice daily for 7 days 1, 3
  • For repeated failure, administer metronidazole 2g once daily for 3-5 days 1, 6
  • If treatment continues to fail and reinfection has been excluded, consultation with an infectious disease specialist is recommended 1
  • Tinidazole may be effective in cases of metronidazole-resistant trichomoniasis, typically at higher doses (2g twice daily for up to 14 days) 8, 9

Important Clinical Considerations

  • Patients should avoid alcohol during treatment with metronidazole and for at least 24 hours afterward due to potential disulfiram-like reactions (nausea, vomiting, flushing, headache) 1, 3
  • For tinidazole, alcohol should be avoided during treatment and for 3 days afterward 4
  • Topical metronidazole gel is NOT effective for trichomoniasis and should not be used (efficacy <50%) 1, 6
  • Taking metronidazole or tinidazole with food helps minimize gastrointestinal side effects 3, 4

Special Situations

  • For patients with HIV infection, the same treatment regimen applies as for HIV-negative individuals 1, 6
  • For patients with true metronidazole allergy, options are limited and desensitization may be required; tinidazole may be considered but cross-reactivity is possible 1, 3

Trichomoniasis is a common sexually transmitted infection that requires appropriate treatment to prevent complications and transmission. While many infected males are asymptomatic, proper treatment is essential to prevent reinfection of partners and potential complications.

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trichomoniasis: clinical manifestations, diagnosis and management.

Sexually transmitted infections, 2004

Research

Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.